Abstract: A respective preferred installation height above ground level is determined for each of a plurality of locations for a subscriber module for receiving a radio link from an access point in a wireless network, the access point having a given height above ground level and a specified location, and the subscriber module being situated within a given geographical area including the location of the access point. The method comprises accessing elevation data for the given geographical area, processing the elevation data to generate a preferred height data file representing a preferred height for a subscriber module to be wirelessly visible by the access point at each of the plurality of locations and processing the required height data file to provide output data indicating the preferred height of the subscriber module as a function of location.

Abstract: A respective preferred installation height above ground level is determined for each of a plurality of locations for a subscriber module for receiving a radio link from an access point in a wireless network, the access point having a given height above ground level and a specified location, and the subscriber module being situated within a given geographical area including the location of the access point. The method comprises accessing elevation data for the given geographical area, processing the elevation data to generate a preferred height data file representing a preferred height for a subscriber module to be wirelessly visible by the access point at each of the plurality of locations and processing the required height data file to provide output data indicating the preferred height of the subscriber module as a function of location.

Abstract: The present invention relates to a liquid pharmaceutical composition suitable for administration by inhalation comprising: (i) ensifentrine particles; (ii) glycopyrrolate; and (iii) a diluent, which diluent comprises water, wherein: the glycopyrrolate is dissolved in the diluent; the concentration of glycopyrrolate is less than or equal to 5.0 mg/mL; and the pH of the liquid pharmaceutical composition is from 3.0 to 6.0. The invention also relates to a nebuliser comprising the liquid pharmaceutical composition.

Abstract: A respective preferred installation height above ground level is determined for each of a plurality of locations for a subscriber module for receiving a radio link from an access point in a wireless network, the access point having a given height above ground level and a specified location, and the subscriber module being situated within a given geographical area including the location of the access point. The method comprises accessing elevation data for the given geographical area, processing the elevation data to generate a preferred height data file representing a preferred height for a subscriber module to be wirelessly visible by the access point at each of the plurality of locations and processing the required height data file to provide output data indicating the preferred height of the subscriber module as a function of location.

Abstract: A respective preferred installation height above ground level is determined for each of a plurality of locations for a subscriber module for receiving a radio link from an access point in a wireless network, the access point having a given height above ground level and a specified location, and the subscriber module being situated within a given geographical area including the location of the access point. The method comprises accessing elevation data for the given geographical area, processing the elevation data to generate a preferred height data file representing a preferred height for a subscriber module to be wirelessly visible by the access point at each of the plurality of locations and processing the required height data file to provide output data indicating the preferred height of the subscriber module as a function of location.

Abstract: A remote treatment system may include a cone assembly including a spine and a cone body at least partially surrounding the spine, a marking payload, a syringe coupled to a portion of the cone assembly and adapted to store a syringe payload for treating a target, and a vanes cup. The vanes cup may have an inner diameter sized to receive an outer diameter of the syringe. The vanes cup may also include stabilization means for stabilizing the remote treatment system. Further, a pressure means within the vanes cup may be configured to apply a pressure against the payload within the syringe. In response to an impact between the cone assembly and the target, the payloads are expressed from the remote treatment system.

Abstract: A remote treatment system may include a cone assembly including a spine and a cone body at least partially surrounding the spine, a marking payload, a syringe coupled to a portion of the cone assembly and adapted to store a syringe payload for treating a target, and a vanes cup. The vanes cup may have an inner diameter sized to receive an outer diameter of the syringe. The vanes cup may also include stabilization means for stabilizing the remote treatment system. Further, a pressure means within the vanes cup may be configured to apply a pressure against the payload within the syringe. In response to an impact between the cone assembly and the target, the payloads are expressed from the remote treatment system.

Abstract: A remote treatment system may include a cone assembly including a spine and a cone body at least partially surrounding the spine, a marking payload, a syringe coupled to a portion of the cone assembly and adapted to store a syringe payload for treating a target, and a vanes cup. The vanes cup may have an inner diameter sized to receive an outer diameter of the syringe. The vanes cup may also include stabilization means for stabilizing the remote treatment system. Further, a pressure means within the vanes cup may be configured to apply a pressure against the payload within the syringe. In response to an impact between the cone assembly and the target, the payloads are expressed from the remote treatment system.